CINFASTROZOLE 1mg Price

Overview

Welcome to Dwaey, specifically on CINFASTROZOLE 1mg Tablets/Film-coated page.
This medicine contains an important and useful components, as it consists of Anastrozole.
CINFASTROZOLE 1mg is available in the market in concentration 1mg/Tablet and in the form of Tablets/Film-coated.

LABORATORIOS CINFA S.A. is the producer of CINFASTROZOLE 1mg and it is imported from SPAIN, The most popular alternatives of CINFASTROZOLE 1mg are listed downward .

Mode Of Action

Anastrozole prevents conversion of androstenedione to estrone and testosterone to oestradiol by inhibiting aromatase, thus leading to significantly reduced serum oestradiol concentrations.

Indication

• Breast cancer
• Ovulation induction

Precaution

Moderate or severe hepatic impairment, hyperlipidaemias. Laboratory test for menopause if status is doubtful. Bone mass density test should be conducted at the start of the therapy and at regular intervals thereafter. Lactation: Unknown whether drug is excreted in milk; not recommended given potential for serious adverse reactions in nursing infants

Side Effects

• >10% Hot flashes (12-36%)
• Vasodilation (25-36%)
• Fatigue (19%)
• Mood disturbances (19%)
• Nausea and vomiting (19%)
• Weakness (16-19%)
• Arthritis (17%)
• Pain (17%)
• Arthralgia (2-15%)
• Pharyngitis (14%)
• Depression (13%)
• Hypertension (2-13%)
• Bone pain (11%)
• Increased cough (11%)
• Osteoporosis (11%)
• Rash (8-11%) 1-10% Accidental injury (10%)
• Back pain (10%)
• Fracture (10%)
• Headache (10%)
• Insomnia (10%)
• Peripheral edema (10%)
• Dyspnea (8-10%)
• Abdominal pain (9%)
• Infection (9%)
• Lymphedema (9%)
• Diarrhea (8-9%)
• Constipation (7-9%)
• Breast pain (8%)
• Dizziness (8%)
• Urinary tract infection (8%)
• Chest pain (7%)
• Dyspepsia (7%)
• Paresthesia (5-7%)
• Anxiety (6%)
• Cataracts (6%)
• Flu syndrome (6%)
• Sinusitis (6%)
• Vulvovaginitis (6%)
• Xerostomia (6%)
• Breast neoplasm (5%)
• Bronchitis (5%)
• Cyst (5%)
• Diaphoresis (5%)
• Neoplasm (5%)
• Vaginal bleeding (5%)
• Fractures of spine
• hip
• or wrist (4%)
• Ischemic cardiovascular disease (4%)
• Vaginal hemorrhage (4%)
• Vaginitis (4%)
• Leukorrhea (3-4%)
• Deep vein thrombosis (2%)
• Endometrial cancer (intact uterus at baseline) (2%)
• Ischemic cerebrovascular event (2%)
• Weight gain (2%)
• Lethargy (1%)

Contra indication

Pregnancy. Hypersensitivity, premenopausal women.

Pregnancy and lactation

Pregnancy category: X

Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.